Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025

Core Insights - Day One Biopharmaceuticals will host a live conference call and webcast on February 25, 2025, at 4:30 p.m. ET to report financial results and discuss corporate progress for Q4 and full-year 2024 [1] - The company focuses on developing targeted therapies for life-threatening diseases in both children and adults, addressing the gap in new therapies due to traditional drug development models [3][4] Company Overview - Day One Biopharmaceuticals is a commercial-stage company dedicated to advancing first- or best-in-class medicines for serious diseases affecting all ages [3] - The company's pipeline includes tovorafenib (OJEMDA™), DAY301, and a VRK1 inhibitor program [5] - The company utilizes its Investor Relations website and social media platforms for disseminating news, financial performance updates, and compliance with disclosure obligations [6]